DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,394,438 | +34.7% | 21,743 | +30.3% | 0.02% | +45.5% |
| Q2 2023 | $4,003,920 | -2.5% | 16,683 | +2.4% | 0.01% | -8.3% |
| Q1 2023 | $4,107,244 | -3.9% | 16,296 | +1.2% | 0.01% | -14.3% |
| Q4 2022 | $4,272,200 | +21.4% | 16,096 | +18.1% | 0.01% | +27.3% |
| Q3 2022 | $3,520,000 | +120.7% | 13,628 | +116.6% | 0.01% | +120.0% |
| Q2 2022 | $1,595,000 | -15.0% | 6,291 | -1.7% | 0.01% | 0.0% |
| Q1 2022 | $1,876,000 | -20.4% | 6,397 | -10.7% | 0.01% | 0.0% |
| Q4 2021 | $2,357,000 | +32.9% | 7,163 | +23.0% | 0.01% | +25.0% |
| Q3 2021 | $1,773,000 | +37.9% | 5,823 | +21.5% | 0.00% | +33.3% |
| Q2 2021 | $1,286,000 | +62.8% | 4,791 | +36.5% | 0.00% | +50.0% |
| Q1 2021 | $790,000 | +1.3% | 3,511 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $780,000 | +7.7% | 3,511 | +4.5% | 0.00% | 0.0% |
| Q3 2020 | $724,000 | +31.2% | 3,360 | +7.6% | 0.00% | 0.0% |
| Q2 2020 | $552,000 | +64.8% | 3,124 | +29.1% | 0.00% | 0.0% |
| Q1 2020 | $335,000 | -0.6% | 2,419 | +10.3% | 0.00% | +100.0% |
| Q4 2019 | $337,000 | +15.0% | 2,194 | +8.1% | 0.00% | 0.0% |
| Q3 2019 | $293,000 | +40.9% | 2,029 | +39.2% | 0.00% | 0.0% |
| Q2 2019 | $208,000 | +11.2% | 1,458 | +3.0% | 0.00% | 0.0% |
| Q1 2019 | $187,000 | +33.6% | 1,415 | +4.3% | 0.00% | 0.0% |
| Q4 2018 | $140,000 | +22.8% | 1,357 | +29.1% | 0.00% | – |
| Q3 2018 | $114,000 | +18.8% | 1,051 | +8.4% | 0.00% | – |
| Q2 2018 | $96,000 | +15.7% | 970 | +14.3% | 0.00% | – |
| Q1 2018 | $83,000 | – | 849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |